Table 5.
Summary of genetic research and tendon injuries: Glycoproteins in the ECM and elastin and fibrillin.
| Type | Protein | Reference | Country | Variant | Pathology | Subjects | Controls | Comments |
|---|---|---|---|---|---|---|---|---|
| Glycoproteins in the ECM | Tenascin-C (TNC) | [74] | South Africa, Australia |
TNC—GT dinucleotide repeats | Achilles’ tendinopathy and rupture | 144 | 127 | Association with the number of GT repeat polymorphism and the risk of tendinopathy and rupture |
| [60] | South Africa, Australia |
TNC rs13321, rs2104772, rs1330363 | Achilles’ tendinopathy and rupture | 179 | 339 | No significant associations found among variants | ||
| [80] | Spain | TNC rs2104772 | Patellar tendon injury | 15 | 0 | No difference between severity of injury and gene variants. No controls were included | ||
| Cartilage oligomeric matrix protein (COMP) | [75] | South Africa, Australia |
COMP rs730079, rs2849450 THBS2 rs9505888 |
Achilles’ tendinopathy and rupture | 178 | 340 | No significant associations found among variants | |
| Elastin and Fibrillin | Elastin (ELN) and Fibrillin (FBN) | [78] | South Africa, Australia |
ELN rs2071307 FBN2 rs331079 |
Achilles’ tendinopathy and rupture | 135 | 239 |
No association with the ELN variant and tendon pathology
Significant association between the FBN2 gene variant and tendon disease |
| [81] | UK | ELN rs2071307 | Achilles’ tendinopathy and rupture | 108 | 131 | No association with the ELN variant and tendon pathology | ||
| [80] | Spain | ELN rs2289630 | Patellar tendon injury | 15 | 0 | No difference between severity of injury and gene variants. No controls were included |
Green indicates an association and red indicates no association found.